Weight loss and Attention deficit hyperactivity disorder

Summary:

Attention deficit hyperactivity disorder is found among people with Weight loss, especially for people who are female, 60+ old.

The study analyzes which people have Attention deficit hyperactivity disorder with Weight loss. It is created by eHealthMe based on reports of 11 people who have Weight loss from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Weight loss?

Weight loss is found to be associated with 1,444 drugs and 2,297 conditions by eHealthMe. Check the latest studies of Weight loss.

What is Attention deficit hyperactivity disorder?

Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness) is found to be associated with 607 drugs and 1,395 conditions by eHealthMe. Check the latest studies of Attention deficit hyperactivity disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 13, 2026

11 people who have Weight Loss and Attention Deficit Hyperactivity Disorder are studied.

Would you have Attention deficit hyperactivity disorder when you have Weight loss?

Gender of people who have Weight Loss and experienced Attention Deficit Hyperactivity Disorder *:

female: 75 %
male: 25 %

Age of people who have Weight Loss and experienced Attention Deficit Hyperactivity Disorder *:

Common co-existing conditions for these people *:

High Blood Cholesterol: 3 people, 27.27%
Diabetes: 3 people, 27.27%
Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 2 people, 18.18%
Growth Hormone Deficiency: 2 people, 18.18%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 18.18%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 18.18%
High Blood Pressure: 2 people, 18.18%
Arrhythmias (irregular heartbeat): 1 person, 9.09%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 1 person, 9.09%
Depression: 1 person, 9.09%

Common drugs taken by these people *:

Common symptoms for these people *:

Insomnia (sleeplessness): 6 people, 54.55%
Headache (pain in head): 6 people, 54.55%
Drowsiness: 5 people, 45.45%
Appetite - Increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires): 5 people, 45.45%
Drug Ineffective: 5 people, 45.45%
Weight Increased: 4 people, 36.36%
Memory Loss: 4 people, 36.36%
Nausea (feeling of having an urge to vomit): 4 people, 36.36%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 36.36%
Depression: 3 people, 27.27%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Attention deficit hyperactivity disorder?

- Check whether Attention deficit hyperactivity disorder is associated with a drug or a condition

Related publications that referenced our studies

Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .

Related studies:

Treatments, associated drugs and conditions:

Weight loss (62,432 reports)
Attention deficit hyperactivity disorder (120,340 reports)

All the drugs that are associated with Attention deficit hyperactivity disorder:

Attention deficit hyperactivity disorder (607 drugs)

All the conditions that are associated with Attention deficit hyperactivity disorder:

Attention deficit hyperactivity disorder (1,395 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Attention deficit hyperactivity disorder and Weight loss, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.